BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22038520)

  • 21. Role of glucokinase in the subcellular localization of glucokinase regulatory protein.
    Jin L; Guo T; Li Z; Lei Z; Li H; Mao Y; Wang X; Zhou N; Zhang Y; Hu R; Zhang X; Niu G; Irwin DM; Tan H
    Int J Mol Sci; 2015 Apr; 16(4):7377-93. PubMed ID: 25849650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.
    Mukhtar MH; Payne VA; Arden C; Harbottle A; Khan S; Lange AJ; Agius L
    Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R766-74. PubMed ID: 18199594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.
    Raimondo A; Rees MG; Gloyn AL
    Curr Opin Lipidol; 2015 Apr; 26(2):88-95. PubMed ID: 25692341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
    Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
    Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of glucokinase regulatory protein expression may contribute to low glucokinase activity in feline liver.
    Hiskett EK; Suwitheechon OU; Lindbloom-Hawley S; Boyle DL; Schermerhorn T
    Vet Res Commun; 2009 Mar; 33(3):227-40. PubMed ID: 18780155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk.
    Reiling E; van 't Riet E; Groenewoud MJ; Welschen LM; van Hove EC; Nijpels G; Maassen JA; Dekker JM; 't Hart LM
    Diabetologia; 2009 Sep; 52(9):1866-70. PubMed ID: 19533084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal and Metabolite Regulation of Hepatic Glucokinase.
    Agius L
    Annu Rev Nutr; 2016 Jul; 36():389-415. PubMed ID: 27146014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte.
    de la Iglesia N; Mukhtar M; Seoane J; Guinovart JJ; Agius L
    J Biol Chem; 2000 Apr; 275(14):10597-603. PubMed ID: 10744755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
    Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From clinicogenetic studies of maturity-onset diabetes of the young to unraveling complex mechanisms of glucokinase regulation.
    Sagen JV; Odili S; Bjørkhaug L; Zelent D; Buettger C; Kwagh J; Stanley C; Dahl-Jørgensen K; de Beaufort C; Bell GI; Han Y; Grimsby J; Taub R; Molven A; Søvik O; Njølstad PR; Matschinsky FM
    Diabetes; 2006 Jun; 55(6):1713-22. PubMed ID: 16731834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits.
    Singh C; Jin B; Shrestha N; Markhard AL; Panda A; Calvo SE; Deik A; Pan X; Zuckerman AL; Ben Saad A; Corey KE; Sjoquist J; Osganian S; AminiTabrizi R; Rhee EP; Shah H; Goldberger O; Mullen AC; Cracan V; Clish CB; Mootha VK; Goodman RP
    Cell Metab; 2024 Jan; 36(1):144-158.e7. PubMed ID: 38101397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
    Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
    Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein.
    Cullen KS; Al-Oanzi ZH; O'Harte FP; Agius L; Arden C
    Biochim Biophys Acta; 2014 Jun; 1843(6):1123-34. PubMed ID: 24566088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevant associations of the glucokinase regulatory protein/glucokinase gene variation with TAG concentrations in a high-cardiovascular risk population: modulation by the Mediterranean diet.
    Sotos-Prieto M; Guillén M; Vicente Sorli J; Portolés O; Guillem-Saiz P; Ignacio Gonzalez J; Qi L; Corella D
    Br J Nutr; 2013 Jan; 109(2):193-201. PubMed ID: 22716779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for regulation of human glucokinase by glucokinase regulatory protein.
    Beck T; Miller BG
    Biochemistry; 2013 Sep; 52(36):6232-9. PubMed ID: 23957911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.
    Slosberg ED; Desai UJ; Fanelli B; St Denny I; Connelly S; Kaleko M; Boettcher BR; Caplan SL
    Diabetes; 2001 Aug; 50(8):1813-20. PubMed ID: 11473043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-receptor substrate-2 (irs-2) is required for maintaining glucokinase and glucokinase regulatory protein expression in mouse liver.
    Roncero I; Alvarez E; Acosta C; Sanz C; Barrio P; Hurtado-Carneiro V; Burks D; Blázquez E
    PLoS One; 2013; 8(4):e58797. PubMed ID: 23560040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. For the ZDF rat, "Breaking up is hard to do": dissociation of the GK:GKRP complex.
    Lange AJ
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1379-80. PubMed ID: 17185403
    [No Abstract]   [Full Text] [Related]  

  • 39. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
    Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; Véniant MM; Hale C
    Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
    Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC
    J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.